The rate filing implements a Board requirement, imposed in connection with GMP’s merger with CVPS, that GMP undergo a comprehensive review of its costs. The filing includes testimony and exhibits of ten witnesses and addresses all aspects of GMP’s costs. It is expected that the Board will suspend implementation of the rate decrease and investigate the filing, with a decision expected later this year. The proposed new alternative regulation plan is intended to take effect at the expiration of the current plan on October 1, 2014. It will also be subject to review over the next several months.